Clinical Trials List
2023-01-31 - 2032-12-03
Phase III
Recruiting11
ICD-10D48.60
Neoplasm of uncertain behavior of unspecified breast
ICD-10D48.61
Neoplasm of uncertain behavior of right breast
ICD-10D48.62
Neoplasm of uncertain behavior of left breast
ICD-9238.3
Neoplasm of uncertain behavior of breast
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 林季宏 Division of Hematology & Oncology
- 蔡立威 Division of General Surgery
- 林柏翰 Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 黃柏翔 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- Wei-Wu Chen Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- Huey-En Tzeng Division of Hematology & Oncology
- I-Chen Tsai Division of General Surgery
- HSIN-CHEN LIN Division of Hematology & Oncology
- 林慈恩 Division of General Surgery
- Kuan-Der Lee Division of Hematology & Oncology
- 王國鐘 Division of General Surgery
- 楊陽生 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊舜如 Division of Hematology & Oncology
- Zhu-Jun Loh Division of General Surgery
- Shang-Hung Chen Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Yao-Lung Kuo Division of General Surgery
- Jui-Hung Tsai Division of Hematology & Oncology
- Kuo-Ting Lee Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- 沈士哲 Division of General Surgery
- 周旭桓 Division of General Surgery
- Pei-Wei Huang Division of Hematology & Oncology
- Chi-Chang Yu Division of General Surgery
- Wen-Ling Kuo Division of General Surgery
- 何蕙余 Division of General Surgery
- Chun-Hsiu Liu Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林燕淑 Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- Chi-Cheng Huang Division of General Surgery
- 馮晉榮 Division of General Surgery
- 賴亦貞 Division of Radiology
- Yi-Fang Tsai Division of General Surgery
- Chun-Yu Liu Division of General Internal Medicine
- 邱仁輝 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- 陳彥蓁 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 巫承哲 Division of General Surgery
- 高理鈞 Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- Fang-Ming Chen Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
73-219 participants
-
Global
8000 participants
